Compounds > pimozide

Page last updated: 2024-08-22

pimozide and Melanoma

pimozide has been researched along with Melanoma in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (57.14)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Chen, J; Feng, Z; Guo, J; Jia, H; Li, J; Li, R; Liu, X; Ren, W; Sun, K; Tian, Z; Wang, M; Wang, P; Wei, T; Yang, Y; Zhao, T; Zhong, J	1
Al-Omaishi, S; Celebre, A; Chan, J; Das, S; Dirks, PB; Ghannad-Zadeh, K; Guan, J; Isaev, K; Kaskun, O; Moran, MF; Morrissy, AS; Munoz, DG; Reimand, J; Sachdeva, R; Smiljanic, S; Taylor, MD; Tong, J; Wilson, TM; Wu, M	1
Koo, J; Lorenzo, CR	1
Baker, MA; Meyskens, FL; Neifeld, JP; Taub, RN; Tormey, DC	1
Krummel, TM; Neifeld, JP; Taub, RN	1
Baker, MA; Taub, RN	1
Comar, D; Maziere, M; Turner, JH	1

Reviews

1 review(s) available for pimozide and Melanoma

Article	Year
Pimozide in dermatologic practice: a comprehensive review. American journal of clinical dermatology, 2004, Volume: 5, Issue:5 Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Delusions; Dermatology; Dopamine Antagonists; Ectoparasitic Infestations; Humans; Hypochondriasis; Melanoma; Neurotic Disorders; Pimozide; Trichotillomania; Trigeminal Neuralgia	2004

Other Studies

6 other study(ies) available for pimozide and Melanoma

Article	Year
A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide. International immunopharmacology, 2020, Volume: 83 Topics: Animals; Antineoplastic Agents; Apoptosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; CpG Islands; Disease Models, Animal; Drug Therapy, Combination; Humans; Immunotherapy; Killer Cells, Natural; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Pimozide; Skin Neoplasms; Toll-Like Receptor 9	2020
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma. Cancer research, 2019, 08-15, Volume: 79, Issue:16 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Inhibitor of Differentiation Protein 1; Melanoma; Mice, Inbred NOD; Phosphorylation; Pimozide; Temozolomide; Xenograft Model Antitumor Assays	2019
Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients. Cancer treatment reports, 1983, Volume: 67, Issue:2 Topics: Adult; Aged; Basal Ganglia Diseases; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pimozide; Skin Neoplasms	1983
Effects of dopamine agonists and antagonists on murine melanoma: correlation with dopamine binding activity. Cancer, 1982, Mar-15, Volume: 49, Issue:6 Topics: Animals; Binding, Competitive; Cell Line; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Pimozide	1982
Treatment of metastatic malignant melanoma with pimozide. Lancet (London, England), 1979, Mar-17, Volume: 1, Issue:8116 Topics: Administration, Oral; Female; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Middle Aged; Neoplasm Metastasis; Pimozide; Skin Neoplasms	1979
Localization of 11C-radiopharmaceuticals in the Greene melanoma of hamsters. European journal of nuclear medicine, 1985, Volume: 10, Issue:9-10 Topics: Animals; Benzodiazepinones; Carbon Radioisotopes; Chlorpromazine; Cricetinae; Flumazenil; Flunitrazepam; Gallium Radioisotopes; Isotope Labeling; Ketanserin; Melanoma; Mesocricetus; Methionine; Neoplasm Transplantation; Pimozide; Piperidines; Quinuclidinyl Benzilate; Radionuclide Imaging; Tissue Distribution	1985